Antioxidant Profile in Patients With Systemic Sclerosis and Periodontitis

Sponsor
University of Belgrade (Other)
Overall Status
Recruiting
CT.gov ID
NCT05215431
Collaborator
(none)
20
1
41.4
0.5

Study Details

Study Description

Brief Summary

The aim of the research will be to compare periodontal status and level of antioxidants in unstimulated saliva of systemic sclerosis patients with periodontitis and systemically healthy periodontitis patients.

Twenty systemic sclerosis patients with periodontitis (SS group) and twenty systemically healthy periodontitis patients (P group) will be enrolled in the present study. The results may indicate higher periodontal destruction and antioxidant perturbations in unstimulated saliva of systemic sclerosis patients with periodontitis compared to systemically healthy periodontitis patients.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: periodontal examination's and determination of salivary antioxidants

Study Design

Study Type:
Observational
Anticipated Enrollment :
20 participants
Observational Model:
Case-Control
Time Perspective:
Cross-Sectional
Official Title:
Antioxidant Profile in Unstimulated Saliva in Patients With Systemic Sclerosis and Periodontitis
Actual Study Start Date :
Feb 5, 2019
Anticipated Primary Completion Date :
Jun 30, 2022
Anticipated Study Completion Date :
Jul 20, 2022

Arms and Interventions

Arm Intervention/Treatment
systemic sclerosis group

Patients with established diagnoses of systemic sclerosis and periodontitis

Diagnostic Test: periodontal examination's and determination of salivary antioxidants
Periodontal parameters such probing depth (PD), clinical attachment level (CAL) and gingival margin level has been recorded on six sites of each tooth using a manual periodontal probe. The degree of gingival inflammation has been assessed using the Loe and Silness (LSGI) gingival index. Activity of antioxidants in unstimulated saliva (GPX, SOD, UA) has been determined using the colorimetric method and commercial kits.

periodontitis group

Systemically healthy periodontitis patients

Diagnostic Test: periodontal examination's and determination of salivary antioxidants
Periodontal parameters such probing depth (PD), clinical attachment level (CAL) and gingival margin level has been recorded on six sites of each tooth using a manual periodontal probe. The degree of gingival inflammation has been assessed using the Loe and Silness (LSGI) gingival index. Activity of antioxidants in unstimulated saliva (GPX, SOD, UA) has been determined using the colorimetric method and commercial kits.

Outcome Measures

Primary Outcome Measures

  1. Clinical attachment level (CAL) [one day]

    Measuring the CAL by periodontal probe, measured in mm

  2. Probing depth (PD) [one day]

    Measuring the PD by periodontal probe, measured in mm

  3. Gingival margin level (GML) [one day]

    Measuring the GML by periodontal probe, measured in mm

  4. The degree of gingival inflammation [one day]

    The degree of gingival inflammation was assessed using the Loe and Silness (LSGI) gingival index.

  5. plaque index (PI) [one day]

    Evaluation of oral hygiene status was recorded with a Silness Loe plaque index (PI).

  6. glutathion peroxidase (GPX) [one day]

    Activity level of GPX, determined using the colorimetric method and commercial kits.

  7. superoxide dismutase (SOD) [one day]

    Activity level of SOD, determined using the colorimetric method and commercial kits.

  8. uric acid (UA) [one day]

    Activity level of UA, determined using the colorimetric method and commercial kits.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • established diagnoses of systemic sclerosis and periodontitis (study group),

  • age ≥ 18

  • presence of minimum 12 teeth

Exclusion Criteria:
  • concurrent inflammatory mediated rheumatic diseases

  • pregnancy or lactation

  • active cigarette smokers

  • a history of periodontal, antibiotics or non-steroidal drug therapy in the past 6 months.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Periodontology and Oral medicine, School of Dental Medicine, University of Belgrade Belgrade Serbia 11000

Sponsors and Collaborators

  • University of Belgrade

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Natasa Nikolic Jakoba, Clinical Professor, University of Belgrade
ClinicalTrials.gov Identifier:
NCT05215431
Other Study ID Numbers:
  • Unique Protocol ID: UBelgrade7
First Posted:
Jan 31, 2022
Last Update Posted:
May 18, 2022
Last Verified:
May 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Natasa Nikolic Jakoba, Clinical Professor, University of Belgrade
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 18, 2022